PEETZ CHRISTOPHER (President and CEO) sold 13.4% of their position (30K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.96M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/3/2026ACC: 0001614740-26-000013
DirectorOfficer· President and CEO
Since Jul 2019
-30K
Net shares
Net seller
$2.96M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+30K
Price / share
$2.94
Trade value
$88.08K
% of position
15.4%
9/1/2026
194.44K→224.44K
Common Stock
Direct
Shares
−8.31K
Price / share
$98.08
Trade value
$815.24K
% of position
3.7%
9/1/2026
224.44K→216.13K
Common Stock
Direct
Shares
−21.69K
Price / share
$98.91
Trade value
$2.15M
% of position
10.0%
9/1/2026
216.13K→194.44K
Total
Net shares
+0.00
Net value
-$2.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +30K | $2.94 | $88.08K | 15.4% | 194.44K | 224.44K |
| Common Stock Direct | 9/1/2026 | S · Sale | −8.31K | $98.08 | $815.24K | 3.7% | 224.44K | 216.13K |
| Common Stock Direct | 9/1/2026 | S · Sale | −21.69K | $98.91 | $2.15M | 10.0% | 216.13K | 194.44K |
| Total | +0.00 | -$2.87M | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
2.936
Held after
58.49K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock30K shares | 9/1/2026 | M · Option Exercise | −30K | 2.936 | — | 58.49K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned187.50K
Total
187.50K indirect187.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 187.50K | Indirect |
| Total | 187.50K | 187.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported